SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001104659-23-030325
Filing Date
2023-03-09
Accepted
2023-03-09 07:26:56
Documents
5
Effectiveness Date
2023-03-09

Document Format Files

Seq Description Document Type Size
1 FORM S-8 tm238784d1_s8.htm S-8 41179
2 EXHIBIT 5.1 tm238784d1_ex5-1.htm EX-5.1 8304
3 EXHIBIT 23.1 tm238784d1_ex23-1.htm EX-23.1 2275
4 EX-FILING FEES tm238784d1_ex-filingfees.htm EX-FILING FEES 18241
5 GRAPHIC tm238784d1_ex5-1img001.jpg GRAPHIC 3465
  Complete submission text file 0001104659-23-030325.txt   75929
Mailing Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142
Business Address 314 MAIN STREET, SUITE 04-200 CAMBRIDGE MA 02142 (857) 400-9491
Theseus Pharmaceuticals, Inc. (Filer) CIK: 0001745020 (see all company filings)

IRS No.: 830712806 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-270382 | Film No.: 23718189
SIC: 2834 Pharmaceutical Preparations